Pharma

Healthcare

Pfizer’s Drug Price Deal with White House Gives Big Pharma a Booster Shot

Photo via imageBROKER/Rupert Oberh�user/Newscom

A 2024 RAND study found that US drug prices are 278% higher than in 33 other developed countries in the OECD.

2 min read

Photo via Image courtesy of Genmab, All rights reserved. © 2024 Genmab A/S

Healthcare

Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus

BMO analysts said in a note Monday they were “encouraged” that Genmab’s acquisition “could start to spur broader M&A in the sector.”

2 min read
Photo via imageBROKER/Marvin Samuel TOLENT/Newscom

Healthcare

Tylenol-Maker’s Shares Sink amid Autism Scrutiny

Studies exploring whether there’s a connection between Tylenol’s key ingredient acetaminophen and autism have had mixed results.

2 min read
Photo via Mu Yu / Xinhua News Agency/Newscom

Healthcare

China’s Multibillion-Dollar US Pharma Pipeline Draws Scrutiny in Washington

China’s pharmaceutical sector, a minor player just years ago, has revved up into a global juggernaut faster than a Fuxing high speed train.

2 min read

Healthcare

Lung Disease Breakthrough Boosts United Therapeutics — and its Rivals

Photo by Robina Weermeijer via Unsplash

About 5 million people are affected by idiopathic pulmonary fibrosis globally, according to the National Institutes of Health.

2 min read

Industries

US Considers Slashing Drug Prices to Match Cheaper Costs Abroad

Photo by Pixabay via Pexels

US President Donald Trump is reportedly considering linking prescription drug prices to their price tags in other developed nations.

2 min read

Healthcare

Pharmapalooza: Earnings Highlight Highs and Lows of Cutthroat Sector

Photo by Veronique D via iStock

It’s just another earnings week in the life of pharmaceutical CEOs, with blockbuster expectations running up against cruel reality.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.